Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Eat Weight Disord ; 22(1): 91-96, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26573986

RESUMEN

PURPOSE: Several studies of school-aged children with attention deficit hyperactivity disorder (ADHD) have found a higher prevalence of overweight/obesity compared with the general population. However, the scientific literature contains insufficient evidence to establish clear conclusions on pulmonary functions, resting metabolic rate (RMR), and body composition in children with ADHD. This study therefore investigates the pulmonary functions tests (PFTs), RMR, and body composition parameters in children with ADHD and evaluates their quality of life. METHODS: Forty children with ADHD and 40 healthy controls participated in the study. The children's parents completed Conners' parent rating scale (CPRS) and the pediatric quality of life (PedsQL), and their teachers completed Conners' Teacher rating scale (CTRS). The child participants also completed the PedsQL. RMR, PFTs, and body composition parameters were investigated. RESULTS: No significant differences in age, gender, and socioeconomic level were found. All CPRS subscales, except anxiety and psychosomatic conditions, were significantly different (p < 0.05). According to the CTRS, inattentiveness, hyperactivity, and conduct problems were significantly higher in the ADHD group. The results showed that the ADHD group's quality of life is worse than the control group. Body mass index, body composition parameters, RMR, and PFTs were not statistically different between the children with ADHD and the healthy controls. CONCLUSIONS: Further studies with complex designs are needed to confirm the results.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/fisiopatología , Metabolismo Basal/fisiología , Composición Corporal/fisiología , Pulmón/fisiopatología , Trastorno por Déficit de Atención con Hiperactividad/diagnóstico , Niño , Femenino , Humanos , Masculino , Calidad de Vida , Pruebas de Función Respiratoria , Índice de Severidad de la Enfermedad
2.
Int J Rheum Dis ; 19(8): 763-72, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24289723

RESUMEN

AIM: The purpose of this study was to investigate the physical fitness parameters (maximal aerobic capacity, muscle strength and flexibility), daily physical activity, resting metabolic rate (RMR), pulmonary function tests (PFTs), body composition, depression, anxiety and health-related quality of life (HRQoL) changes as well as the associations among these parameters in patients with fibromyalgia and to compare them with healthy controls. METHODS: Thirty-nine women with fibromyalgia and 40 controls were included in this study. Physical measurements, HRQoL questionnaire, Beck Depression Inventory (BDI) score and Beck Anxiety Inventory (BAI) score were applied to all participants. RESULTS: Maximal aerobic capacity, trunk flexibility, daily step numbers, total energy expenditure, RMR and PFT values were not significantly different between the patients and the controls. Fibromyalgia patients had higher daily moderate activity times, active energy expenditure values, and BDI and BAI scores, while their lower handgrip strength and back-leg strength values and Short-form health survey (SF)-36 scores were comparable to controls. Handgrip strength and back-leg strength values showed moderately positive correlations with SF-36 scores (total, physical health, mental health) and moderately negative correlations with BDI and BAI scores in patients with fibromyalgia. CONCLUSION: Our results suggested that muscle strength, HRQoL, depression and anxiety symptomatology were impaired in fibromyalgia patients compared to healthy controls. Low muscle strength is related to reduced HRQoL and increased depression and anxiety symptomatology in patients with fibromyalgia. Also we suggest that performing daily exercises, including aerobic and strength training, as part of one's lifestyle may have beneficial effects in fibromyalgia patients.


Asunto(s)
Ansiedad/etiología , Depresión/etiología , Fibromialgia/complicaciones , Aptitud Física , Calidad de Vida , Adulto , Ansiedad/diagnóstico , Ansiedad/fisiopatología , Ansiedad/psicología , Estudios de Casos y Controles , Depresión/diagnóstico , Depresión/fisiopatología , Depresión/psicología , Metabolismo Energético , Tolerancia al Ejercicio , Femenino , Fibromialgia/diagnóstico , Fibromialgia/fisiopatología , Fibromialgia/psicología , Estado de Salud , Humanos , Pulmón/fisiopatología , Salud Mental , Persona de Mediana Edad , Fuerza Muscular , Pronóstico , Rango del Movimiento Articular , Pruebas de Función Respiratoria , Encuestas y Cuestionarios
3.
Psychiatry Res ; 210(3): 806-11, 2013 Dec 30.
Artículo en Inglés | MEDLINE | ID: mdl-24113123

RESUMEN

The aims of this study were to compare aerobic and anaerobic exercise capacities, pulmonary functions, body composition and fat distribution parameters in patients with schizophrenia and healthy controls and to investigate the associations among these parameters. Sixty (30 male, 30 female) patients with schizophrenia and 60 (30 male, 30 female) healthy controls were included in the study. Maximal aerobic capacity was estimated with the Astrand submaximal exercise protocol, and anaerobic performance was determined with a Wingate test. Body composition was established with a bioelectrical impedance analyzer. Pulmonary function tests, skinfold thickness and body circumference measurements were also carried out. Maximal aerobic capacity, maximal anaerobic power, anaerobic capacity and pulmonary function tests (forced vital capacity and maximal voluntary ventilation) were found to be lower in male and female schizophrenic groups as compared to the controls. Body fat percentage, waist and abdomen circumferences, and waist to hip ratio were found to be higher in female schizophrenic patients than in controls. We suggest that maximal aerobic capacity, maximal anaerobic power, and anaerobic capacity are poor in the schizophrenia patients as compared to healthy controls. Low cardiorespiratory fitness is related to reduced pulmonary function and impaired body composition in schizophrenia patients.


Asunto(s)
Tolerancia al Ejercicio , Aptitud Física , Esquizofrenia/metabolismo , Esquizofrenia/fisiopatología , Adulto , Composición Corporal , Distribución de la Grasa Corporal , Estudios de Casos y Controles , Metabolismo Energético , Ejercicio Físico , Prueba de Esfuerzo , Femenino , Estado de Salud , Humanos , Masculino , Persona de Mediana Edad , Consumo de Oxígeno , Esquizofrenia/diagnóstico , Grosor de los Pliegues Cutáneos
4.
Int J Dermatol ; 52(9): 1129-34, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23879519

RESUMEN

The aim of this study was to compare aerobic exercise capacity, daily physical activity, pulmonary functions, resting metabolic rate, and body composition parameters in patients with psoriasis and healthy controls. A total of 60 participants (30 [15 men, 15 women] patients with psoriasis, and 30 [15 men, 15 women] healthy controls) ranging in age from 22-57 were included in the study. Maximal aerobic capacity was determined by Astrand exercise protocol. Daily physical activity was measured with an accelerometer. Resting metabolic rate was determined with an indirect calorimeter. Pulmonary function tests were performed with a portable spirometer. Body composition was established with a bioelectric impedance analysis system. Skinfold thicknesses and body circumference measurements were carried out. Short Form 36 quality of life questionnaire was applied to all participants. In both genders, daily physical activity parameters were found to be higher in the psoriasis group compared to the control. Maximal aerobic capacity, resting metabolic rate, pulmonary function tests, body fatness, body fat distributions, and quality of life were not statistically different between patients with psoriasis and controls in males and females. We suggest that patients with psoriasis who do not have psoriatic arthritis or severe psoriasis are well in performing daily physical activities. In addition, we suggest that this lifestyle helped to prevent impairments of body fatness, body fat distributions, resting metabolic rate, pulmonary functions, and quality of life in patients with mild to moderate psoriasis.


Asunto(s)
Acelerometría/métodos , Tolerancia al Ejercicio/fisiología , Ejercicio Físico/fisiología , Psoriasis/fisiopatología , Conducta Sedentaria , Adulto , Femenino , Estado de Salud , Humanos , Masculino , Persona de Mediana Edad , Consumo de Oxígeno/fisiología , Calidad de Vida , Grosor de los Pliegues Cutáneos , Adulto Joven
5.
Neurol Sci ; 34(2): 225-9, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22391675

RESUMEN

Topiramate is an anticonvulsant agent effective in the prophylaxis of migraine, which also induces weight reduction by an unknown mechanism. We investigated the effect of topiramate on resting metabolic rate, anthropometric measurements, and body composition in patients with migraine independently from any intention to lose body weight. Forty patients (18-71 years old) with migraine were treated with 100 mg of topiramate/day over a period of 3 months. Anthropometric measurements, body fat proportions and resting metabolic rates of these patients were measured before and after treatment. At the end of 3 months, we detected mean 0.8 kg reduction in body weight and 0.3 kg/m(2) reduction in body mass index (BMI). Waist circumference decreased significantly (p = 0.01). Body fat ratio decreased (p = 0.016). Abdominal skinfold measurements decreased after treatment (p = 0.048); however, no difference was found in other regions (p > 0.05). We did not find a significant difference in resting metabolic rate (p > 0.05).These TPM-treated patients lost weight and had reduction in their mean BMI. It was seen that patients lost weight from body fat tissue and central area. We saw that TPM'S weight-reducing effect was independent from resting metaobolic rate. The weight-reducing effect of TPM may result from changes on the hypothalamus.


Asunto(s)
Metabolismo Basal/efectos de los fármacos , Composición Corporal/efectos de los fármacos , Fructosa/análogos & derivados , Trastornos Migrañosos/tratamiento farmacológico , Adolescente , Adulto , Anciano , Peso Corporal/efectos de los fármacos , Femenino , Fructosa/farmacología , Fructosa/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Trastornos Migrañosos/metabolismo , Estudios Prospectivos , Topiramato , Resultado del Tratamiento , Pérdida de Peso/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...